litlas
ログインアカウント作成

Stefano Bellentani

1982–2021 年に発表

46
論文数
17,960
被引用数
42
h 指数
46
i10 指数

被引用数

Stefano Bellentani の年別被引用数1984 年: 被引用 1 件1986 年: 被引用 1 件1988 年: 被引用 1 件1990 年: 被引用 2 件1991 年: 被引用 4 件1992 年: 被引用 1 件1993 年: 被引用 1 件1994 年: 被引用 2 件1995 年: 被引用 3 件1996 年: 被引用 7 件1997 年: 被引用 8 件1998 年: 被引用 11 件1999 年: 被引用 16 件2000 年: 被引用 27 件2001 年: 被引用 45 件2002 年: 被引用 44 件2003 年: 被引用 41 件2004 年: 被引用 80 件2005 年: 被引用 68 件2006 年: 被引用 89 件2007 年: 被引用 80 件2008 年: 被引用 94 件2009 年: 被引用 107 件2010 年: 被引用 112 件2011 年: 被引用 145 件2012 年: 被引用 156 件2013 年: 被引用 205 件2014 年: 被引用 233 件2015 年: 被引用 193 件2016 年: 被引用 188 件2017 年: 被引用 212 件2018 年: 被引用 182 件2019 年: 被引用 680 件2020 年: 被引用 705 件2021 年: 被引用 763 件2022 年: 被引用 606 件2023 年: 被引用 448 件2024 年: 被引用 576 件2025 年: 被引用 270 件2026 年: 被引用 2 件1985 年は被引用が無いため表示していません1987 年は被引用が無いため表示していません1989 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,509 件、この内訳の 17.9%中国: 引用元論文 966 件、この内訳の 11.5%イタリア: 引用元論文 831 件、この内訳の 9.9%イギリス: 引用元論文 528 件、この内訳の 6.3%ドイツ: 引用元論文 359 件、この内訳の 4.3%韓国: 引用元論文 336 件、この内訳の 4%日本: 引用元論文 297 件、この内訳の 3.5%スペイン: 引用元論文 278 件、この内訳の 3.3%フランス: 引用元論文 263 件、この内訳の 3.1%オーストラリア: 引用元論文 227 件、この内訳の 2.7%カナダ: 引用元論文 164 件、この内訳の 1.9%スウェーデン: 引用元論文 160 件、この内訳の 1.9%
0%17.9%その他 29.7%

機関

分野

  • Medicine88.5%
  • Biochemistry, Genetics and Molecular Biology6.5%
  • Nursing0.9%
  • Immunology and Microbiology0.8%
  • Agricultural and Biological Sciences0.7%
  • Neuroscience0.5%
  • その他2.1%

トピック

  • Liver Disease Diagnosis and Treatment27.3%
  • Diet, Metabolism, and Disease7.3%
  • Liver Disease and Transplantation6.5%
  • Alcohol Consumption and Health Effects5.8%
  • Diabetes, Cardiovascular Risks, and Lipoproteins5.3%
  • Hepatitis C virus research2.8%
  • その他45%

共著者

全論文

検索で開く
  1. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population

    著者: Giorgio Bedogni, Stefano Bellentani, L. Miglioli, Flora Masutti, Marilena Passalacqua, Anna Castiglione, Claudio Tiribelli - BMC Gastroenterology 2006 被引用: 3,071

  2. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030

    著者: Chris Estes, Quentin M. Anstee, M. Arias, Heike Bantel, Stefano Bellentani, Joan Caballería, Massimo Colombo, Antonio Craxı̀, Javier Crespo, Christopher P. Day, Yuichiro Eguchi, Andreas Geier, Loreta A. Kondili, Daniela C. Kroy, Jeffrey V. Lazarus, Rohit Loomba, Michael P. Manns, Giulio Marchesini, Atsushi Nakajima, Francesco Negro, Salvatore Petta, Vlad Ratziu, Manuel Romero‐Gómez, Arun J. Sanyal, Jörn M. Schattenberg, Frank Tacke, Junko Tanaka, Christian Trautwein, Lai Wei, Stefan Zeuzem, Homie Razavi - Journal of Hepatology 2018 被引用: 2,008

  3. Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study

    著者: Fabio Piscaglia, Gianluca Svegliati‐Baroni, Andrea Barchetti, Anna Pecorelli, Sara Marinelli, Claudio Tiribelli, Stefano Bellentani, on behalf of the HCC‐NAFLD Italian Study Group - Hepatology 2015 被引用: 596

  4. A position statement on NAFLD/NASH based on the EASL 2009 special conference

    著者: Vlad Ratziu, Stefano Bellentani, Helena Cortez‐Pinto, Chris Day, Giulio Marchesini - Journal of Hepatology 2010 被引用: 1,061

  5. The epidemiology of non‐alcoholic fatty liver disease

    著者: Stefano Bellentani - Liver International 2017 被引用: 606

  6. Global epidemiology of non‐alcoholic fatty liver disease/non‐alcoholic steatohepatitis: What we need in the future

    著者: Ana Ruth Araújo, Natalia Rosso, Giorgio Bedogni, Claudio Tiribelli, Stefano Bellentani - Liver International 2018 被引用: 418

  7. Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence

    著者: Arrigo F.G. Cicero, Alessandro Colletti, Stefano Bellentani - Nutrients 2018 被引用: 179

  8. Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups

    著者: Amedeo Lonardo, Stefano Bellentani, Curtis K. Argo, Stefano Ballestri, Christopher D. Byrne, Stephen H. Caldwell, Helena Cortez‐Pinto, Antonio Grieco, Mariana Verdelho Machado, Luca Miele, Giovanni Targher - Digestive and Liver Disease 2015 被引用: 442

  9. Prevalence of and Risk Factors for Nonalcoholic Fatty Liver Disease: The Dionysos Nutrition and Liver Study * #

    著者: Giorgio Bedogni, L. Miglioli, Flora Masutti, Claudio Tiribelli, Giulio Marchesini, Stefano Bellentani - Hepatology 2005 被引用: 1,268

  10. Epidemiology of Non-Alcoholic Fatty Liver Disease

    著者: Stefano Bellentani, Federica Scaglioni, Mariano Marino, Giorgio Bedogni - Digestive Diseases 2010 被引用: 1,036

  11. Cow’s Milk Consumption and Health: A Health Professional’s Guide

    著者: Franca Marangoni, L. Pellegrino, Elvira Verduci, Andrea Ghiselli, Roberto Bernabei, Riccardo Calvani, Irene Cetin, Michelangelo Giampietro, Francesco Perticone, Luca Piretta, Rosalba Giacco, Carlo La Vecchia, Maria Luisa Brandi, Donatella Ballardini, Giuseppe Banderali, Stefano Bellentani, Giuseppe Canzone, Claudio Cricelli, Pompilio Faggiano, Nicola Ferrara, Evelina Flachi, Stefano Gonnelli, Claudio Macca, Paolo Magni, Giuseppe Marelli, Walter Marrocco, Vito Leonardo Miniello, Carlo Origo, Filomena Pietrantonio, Paolo Silvestri, Roberto Stella, Pasquale Strazzullo, Ersilia Troiano, Andrea Poli - Journal of the American College of Nutrition 2018 被引用: 133

  12. AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions

    著者: Amedeo Lonardo, Fabio Nascimbeni, Giovanni Targher, Mauro Bernardi, Ferruccio Bonino, Elisabetta Bugianesi, Alessandro Casini, Amalia Gastaldelli, Giulio Marchesini, Fabio Marra, Luca Miele, Filomena Morisco, Salvatore Petta, Fabio Piscaglia, Gianluca Svegliati‐Baroni, Luca Valenti, Stefano Bellentani - Digestive and Liver Disease 2017 被引用: 307

  13. A simple index of lipid overaccumulation is a good marker of liver steatosis

    著者: Giorgio Bedogni, Henry S. Kahn, Stefano Bellentani, Claudio Tiribelli - BMC Gastroenterology 2010 被引用: 251

  14. Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy

    著者: Stefano Bellentani, Gioconda Saccoccio, Flora Masutti, Lory Saveria Crocè, Giovanni Brandi, Franco Sasso, Giovanni Cristanini, Claudio Tiribelli - Annals of Internal Medicine 2000 被引用: 1,266

  15. From NAFLD in clinical practice to answers from guidelines

    著者: Fabio Nascimbeni, Raluca Pais, Stefano Bellentani, Christopher P. Day, Vlad Ratziu, Paola Loria, Amedeo Lonardo - Journal of Hepatology 2013 被引用: 338

  16. Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference

    著者: M. Munteanu, Dina Tiniakos, Quentin M. Anstee, Frédéric Charlotte, Giulio Marchesini, Elisabetta Bugianesi, Michael Trauner, M. Romero Gomez, Cláudia P. Oliveira, Christopher P. Day, Jean‐François Dufour, Stefano Bellentani, Yen Ngo, S. Traussnig, Hugo Perazzo, Olivier Deckmyn, Pierre Bédossa, Vlad Ratziu, Thierry Poynard - Alimentary Pharmacology & Therapeutics 2016 被引用: 92

  17. The Fatty liver Index (FLI) 15 years later: a reappraisal

    著者: Amedeo Lonardo, Stefano Ballestri, Giorgio Bedogni, Stefano Bellentani, Claudio Tiribelli - Metabolism and Target Organ Damage 2021 被引用: 32

  18. Drinking habits as cofactors of risk for alcohol induced liver damage

    著者: Stefano Bellentani, Gioconda Saccoccio, Guilherme Crispim Costa, Claudio Tiribelli, Flavio Manenti, Marino Sodde, Lory Saveria Crocè, Franco Sasso, Gabriele Pozzato, G Cristianini, G Brandi and the Dionysos Study Group - Gut 1997 被引用: 627

  19. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease

    著者: Paola Loria, Luigi Elio Adinolfi, Stefano Bellentani, Elisabetta Bugianesi, Antonio Grieco, Silvia Fargion, Antonio Gasbarrini, C. Loguercio, Amedeo Lonardo, Giulio Marchesini, Fabio Marra, Marcello Persico, Daniele Prati, Gianluca Svegliati‐Baroni - Digestive and Liver Disease 2010 被引用: 292

  20. Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach

    著者: Stefano Bellentani, Riccardo Dalle Grave, Alessandro Suppini, Giulio Marchesini - Hepatology 2007 被引用: 239

  21. A survey of pharmacological and nonpharmacological treatment of functional gastrointestinal disorders

    著者: Edith Lahner, Stefano Bellentani, Rudy De Bastiani, Cesare Tosetti, Michele Cicala, Gianluca Esposito, Paolo Arullani, Bruno Annibale, Study Group Primary Care in Gastroenterology of the Italian Society of Gastroenterology - United European Gastroenterology Journal 2013 被引用: 87

  22. Stage of change and motivation to healthier lifestyle in non-alcoholic fatty liver disease

    著者: Elena Centis, Simona Moscatiello, Elisabetta Bugianesi, Stefano Bellentani, Anna Ludovica Fracanzani, Simona Calugi, Salvatore Petta, Riccardo Dalle Grave, Giulio Marchesini - Journal of Hepatology 2012 被引用: 92

  23. Natural Course of Chronic HCV and HBV Infection and Role of Alcohol in the General Population: The Dionysos Study

    著者: Giorgio Bedogni, L. Miglioli, Flora Masutti, S. Ferri, Anna Castiglione, Marco Lenzi, Lory Saveria Crocè, Alessandro Granito, Claudio Tiribelli, Stefano Bellentani - The American Journal of Gastroenterology 2008 被引用: 89

  24. Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD)

    著者: Stefano Bellentani, Mariano Marino - Annals of Hepatology 2009 被引用: 320